Pericytes and the pathogenesis of diabetic retinopathy

被引:170
作者
Hammes, HP [1 ]
机构
[1] Univ Heidelberg, Univ Hosp Mannheim, Med Dept 5, D-68167 Mannheim, Germany
关键词
diabetic retinopathy; pericytes; microangiopathy; capillaries;
D O I
10.1055/s-2005-861361
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
incipient diabetic retinopathy is characterized by increased vascular permeability and progressive Vascular occlusion. Pericyte loss precedes capillary occlusion in the diabetic retina, but its cause remains unclear. One concept proposes that pericyte loss is the result of toxic product accumulation and induction of destructive cellular signals generated within the pericyte. Alternatively, new experimental data indicate that pericyte dropout may result from regulations which induce pericyte elimination as an active process. Pericytes are critical for the development of a proper retinal network, and appear protective for endothelial cells tinder hyperglycemic conditions. The unifying hypothesis of hyperglycemia-induced microvascular damage centers around hyperglycemia-induced mitochondrial overproduction of reactive oxygen species. The pharmacological prevention of acellular capillaries without the rescue of pericyte loss in experimental diabetic retincipathy suggests that the endothelium is the primary therapeutic target.
引用
收藏
页码:S39 / S43
页数:5
相关论文
共 28 条
[11]   Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy [J].
Hammes, HP ;
Du, XL ;
Edelstein, D ;
Taguchi, T ;
Matsumura, T ;
Ju, QD ;
Lin, JH ;
Bierhaus, A ;
Nawroth, P ;
Hannak, D ;
Neumaier, M ;
Bergfeld, R ;
Giardino, I ;
Brownlee, M .
NATURE MEDICINE, 2003, 9 (03) :294-299
[12]   Pericytes and the pathogenesis of diabetic retinopathy [J].
Hammes, HP ;
Lin, JH ;
Renner, O ;
Shani, M ;
Lundqvist, A ;
Betsholtz, C ;
Brownlee, M ;
Deutsch, U .
DIABETES, 2002, 51 (10) :3107-3112
[13]   The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster [J].
Hammes, HP ;
Wellensiek, B ;
Klöting, I ;
Sickel, E ;
Bretzel, RG ;
Brownlee, M .
DIABETOLOGIA, 1998, 41 (02) :165-170
[14]   AMINOGUANIDINE TREATMENT INHIBITS THE DEVELOPMENT OF EXPERIMENTAL DIABETIC-RETINOPATHY [J].
HAMMES, HP ;
MARTIN, S ;
FEDERLIN, K ;
GEISEN, K ;
BROWNLEE, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11555-11558
[15]  
Hellström M, 1999, DEVELOPMENT, V126, P3047
[16]   Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis [J].
Hellström, M ;
Gerhardt, H ;
Kalén, M ;
Li, XR ;
Eriksson, U ;
Wolburg, H ;
Betsholtz, C .
JOURNAL OF CELL BIOLOGY, 2001, 153 (03) :543-553
[17]   ALDOSE REDUCTASE AND POLYOL IN CULTURED PERICYTES OF HUMAN RETINAL CAPILLARIES [J].
HOHMAN, TC ;
NISHIMURA, C ;
ROBISON, WG .
EXPERIMENTAL EYE RESEARCH, 1989, 48 (01) :55-60
[18]   Molecular regulation of vessel maturation [J].
Jain, RK .
NATURE MEDICINE, 2003, 9 (06) :685-693
[19]   Pericyte loss and microaneurysm formation in PDGF-B-deficient mice [J].
Lindahl, P ;
Johansson, BR ;
Leveen, P ;
Betsholtz, C .
SCIENCE, 1997, 277 (5323) :242-245
[20]   Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall [J].
Lindblom, P ;
Gerhardt, H ;
Liebner, S ;
Abramsson, A ;
Enge, M ;
Hellström, M ;
Bäckström, G ;
Fredriksson, S ;
Landegren, U ;
Nyström, HC ;
Bergström, G ;
Dejana, E ;
Östman, A ;
Lindahl, P ;
Betsholtz, C .
GENES & DEVELOPMENT, 2003, 17 (15) :1835-1840